PLAAT5 (NM_001146728) Human Recombinant Protein

Product Specifications

Background

Exhibits both phospholipase A1/2 and acyltransferase activities (PubMed:22825852, PubMed:26503625) . Shows phospholipase A1 (PLA1) and A2 (PLA2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids (PubMed:22825852) . Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs) (PubMed:19000777, PubMed:22825852) .[UniProtKB/Swiss-Prot Function]

Overview

Purified recombinant protein of Human HRAS-like suppressor family, member 5 (HRASLS5), transcript variant 3, full length, with N-terminal HIS tag, expressed in E. coli, 50ug

Synonyms

HRASLS5; HRLP5; HRSL5; iNAT; PLAAT-5; RLP1

Gene ID

117245

UniProt

Q8NE88, B4DY88

Accession Number mRNA

NM_001146728

Chromosomal Location

11q12.3

Expression System

E. coli

Tag

N-His

Concentration

>50 ug/mL as determined by microplate BCA method

Purity

> 80% as determined by SDS-PAGE and Coomassie blue staining

Form

Liquid

Buffer

25mM Tris, pH8.0, 150mM NaCl, 10% glycerol, 1 % Sarkosyl.

Molecular Weight

27.5 kDa

Storage Conditions

Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.